Aimia Inc. (TSX: AIM) announced that it repurchased and settled for cancellation a total of 136,300 of its common shares in the month of January 2026 under the Company's normal course issuer bid ...

CorMedix Therapeutics shares were 6.1% higher, at $8.23, after the company said its board of directors has approved a share-repurchase program authorizing it to buy up to $75 million of the company's ...

Swiss Re remains a Buy, driven by robust earnings growth and a strong solvency ratio. Q1 results exceeded expectations, with net profit boosted by lower tax and investment gains, and core ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Mogo Inc. (“Mogo” or the “Company”) (NASDAQ: MOGO; TSX: MOGO), a Canadian financial technology company offering solutions across wealth, lending, and ...

Athene Holding Ltd. will redeem all outstanding Series C Preferred Stock shares on June 30, 2025, at $25.00 each. Athene Holding Ltd. announced that it will redeem all outstanding shares of its 6.375% ...